| Financial Year |
March 31 2023 |
| Monetary Funds |
479,747,899.25 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
151,314,159.05 |
| Advances to Suppliers |
82,921,904.22 |
| Other Receivables |
2,518,235.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
378,790,264.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,584,101.45 |
| Total Current Assets |
1,115,134,935.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
480,946,840.19 |
| Under-construction Projects |
369,482,914.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
107,135,625.57 |
| R&D expenses |
-- |
| Goodwill |
18,023,616.11 |
| Long-Term Deferred and Prepaid Expenses |
5,095,317.97 |
| Deferred Income Tax Assets |
4,587,298.16 |
| Other Non-Current Assets |
16,472,885.17 |
| Sub-Total of Non-Current Assets |
1,001,744,497.86 |
| Total Assets |
2,116,879,433.29 |
| Short-Term Loans |
280,157,166.67 |
| Trading Financial liabilities |
-- |
| Notes Payable |
57,039,100.00 |
| Accounts Payable |
13,841,359.57 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
795,078.99 |
| Taxes Payable |
1,702,220.12 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,675,308.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,400,000.00 |
| Other Current Liabilities |
1,180.41 |
| Sub-Total of Current Liabilities |
361,620,494.60 |
| Long-term Loans |
283,915,082.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,974,282.77 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
319,144,789.72 |
| Total Liabilities |
680,765,284.32 |
| Paid-In Capital(Or Share Stock) |
346,000,000.00 |
| Capital Surplus |
561,025,368.32 |
| Surplus Reserve |
35,980,079.37 |
| LESS:Treasury Stock |
12,964,253.70 |
| Undistributed Profits |
506,072,954.98 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,436,114,148.97 |
| Owner's Equity（Stockholder's Equity） |
1,436,114,148.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,116,879,433.29 |
